Vertex Pharmaceuticals Inc
NASDAQ: VRTX
$490.00
-$11.72 (-2.3%)
Closing Price on November 12, 2024
VRTX Articles
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Friday. The Active Network Inc. (NYSE: ACTV) cut to Market Perform at Raymond James and cut...
Published:
Last Updated:
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals...
Published:
Last Updated:
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday. Apple Inc. (NASDAQ: AAPL) reiterated Outperform with $750 target at...
Published:
Last Updated:
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement date....
Published:
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short...
Published:
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short...
Published:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday morning. Amgen Inc. (NASDAQ: AMGN) raised to Buy at Lazard. American Tower...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday morning. Broadsoft Inc. (NASDAQ: BSFT) raised to Buy at Goldman Sachs....
Published:
Last Updated:
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the M&A block. Monday’s...
Published:
Last Updated:
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in the biotech and emerging...
Published:
Last Updated:
The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it is...
Published:
Last Updated:
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was very close to 52-week highs of late, but that will not be the case now. The company updated information that is being called a correction...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday. Banco Bilbao Vizcaya Argentaria (NYSE: BBVA) Cut to Sell at Societe...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Thursday. ARM Holdings PLC (NASDAQ: ARMH) Raised to Market Perform at Bernstein. Big...
Published:
Last Updated: